Pharmacology & Toxicology Poster Session |
Introduction
Bronchial asthma is a chronic respiratory recurrent disease universally distributed. Asthma prevalence in Cuba is 8,2%. In the latest years there has been an increase of asthma morbidity and mortality in many countries, including ours. In Cuba, Family Physicians are in charge of asthmatic patients’ treatment with the purpose to improve their quality of life. Frequently preventive and symptomatic drugs are prescribed inadequately and are not assessed from the epidemiological point of view. Relevant issues towards drug use have been taking place in Cuba: development and consolidation of national drug program, projects addressed to improve drug information (Therapeutic Guideline 1994, bulletins, etc.) and even more recently the establishment of Drugs and Therapeutics Committee in each municipality, headed by a Family Physician. All these facts have stimulated for drug utilization researches (DUR) all together between prescribers and other health professionals. In 1995 a DUR was performed about drug utilization in asthma treatment, analyzing three health areas in different provinces; Havana City, Villa Clara and Camaguey, with the purpose of identifying the most frequently used drug to treat bronchial asthma and the treatment schedules applied in Primary Health Care.
| Discussion Board | Next Page | Your Poster Session | |
||||||||||
Cires, M; Zapata, A; Sinclair, G; Portuondo, C; (1998). Drug Utilization Study in Bronchial Asthma Treatment. Presented at INABIS '98 - 5th Internet World Congress on Biomedical Sciences at McMaster University, Canada, Dec 7-16th. Available at URL http://www.mcmaster.ca/inabis98/pharmtox/cires0750/index.html | |||||||||||
© 1998 Author(s) Hold Copyright |